top of page


mast celL actIvatIon
Mast Cell Activation (MCA) is the process by which mast cells, which are granule-rich immune cells found in connective tissues and mucosal surfaces, become activated and release various bioactive mediators. These mediators include predominantly histamine, but also tryptase, cytokines, prostaglandins, and leukotrienes, all of which orchestrate inflammatory and allergic responses.
Activation of the mast cell is dependent on it being crosslinked with what is determined as an allergen. The accurate determination of a substance being friend or foe to the body is of primary importance when Mast Cell Activation is excessive, but the exposure is non-threatening.
Under normal conditions, the immune system learns to tolerate harmless environmental substances such as pollen, food proteins, or pet dander through early-life exposure, gut immune signaling, and the training of regulatory T cells (Tregs). This involves specialized immune cells, such as dendritic cells, presenting foreign substances (antigens) to naive T cells, encouraging the development of tolerance, rather than an immune response.
However, when this system fails for a variety of reasons including genetic predisposition, environmental toxins, dysbiosis of the gut microbiota, impaired gut barrier function, or nutritional deficiencies, the immune system may misidentify a harmless substance as a threat. This causes the immune system to react in a way that favors a response known as a Th2-type reaction. In this type of response, the body makes IgE antibodies that are specially designed to target that harmless substance on-going.
These IgE antibodies then bind to the surface of mast cells, “arming” them for a future response. On subsequent exposures to the same substance, the allergen crosslinks the IgE on these cells, triggering the release of histamine and other inflammatory mediators into the local environment. The impact histamine has on the body depends on the location and receptor subtype that is activated. There are 4 histamine receptors, these include:
H1 Receptor
Location: Nose, skin, lungs, blood vessels, brain
-
Triggers allergic symptoms: itching, sneezing, mucus production, hives
-
Causes bronchoconstriction in asthma
-
Increases blood vessel permeability (swelling, redness)
-
Affects sleep-wake regulation
H2 Receptor
Location: Stomach lining, heart, blood vessels, some immune cells
-
Stimulates gastric acid secretion
-
Causes vasodilation (widens blood vessels)
-
Modulates heart rate and immune cell activity
H3 Receptor
Location: Brain and nervous system
-
Controls the release neurotransmitters like dopamine, acetylcholine
-
Plays a role in sleep, cognition, appetite, and neuroinflammation
H4 Receptor
Location: Bone marrow, spleen, immune cells
-
Promotes inflammation in allergic diseases. E.g., asthma, dermatitis
-
Potential target for autoimmune and chronic inflammatory diseases
Although histamine is physiologically necessary for processes such as gastric acid secretion and neurotransmission, or clearing valid threats, such as chemicals or mould. It is when Mast cells activation and histamine release is excessive and unnecessary that is problematic.
Uncontrolled mast cell activation leads to persistent and systemic inflammation, impacting quality of life and increasing the risk of secondary conditions, such as autoimmune diseases, chronic gastrointestinal inflammation, and psychiatric manifestations, such as anxiety and brain fog.
Mainstream treatments like antihistamines and corticosteroids fail to address the underlying mast cell dysregulation. First-generation antihistamines cause drowsiness and cognitive impairment, while newer agents, although better tolerated, only block histamine from binding to its receptor. They don’t stop mast cells from releasing histamine or other inflammatory chemicals.
Therefore holistic approaches, including nutritional therapy, mast cell stabilisers, and gut microbiome modulation, are essential. Addressing the root of mast cell hyperactivity not only provides symptomatic relief but also helps restore immune tolerance, reduce inflammation, and prevent chronic allergic progression.
signs & symptoms
Mast cell activation results in the release of over 200 bioactive mediators. These mediators can affect a variety of tissues and organ systems in a variety of ways. Each system and the implication of mast cell activation within it are detailed below, please read what is relevant to you.
Gastrointestinal Signs + Symptoms
-
Abdominal Discomfort
-
Abdominal Distension
-
Nausea
-
Heartburn / Reflux
-
Diarrhoea, or altered bowel habits.
Mast cells are abundant in the gastrointestinal mucosa and submucosa. Upon activation, histamine is released and binds primarily to H1 and H2 receptors on smooth muscle cells and enteric neurons. H1 activation promotes smooth muscle contraction, contributing to abdominal cramping, altered bowel motions or diarrhoea.
In relation to the abdominal distention, this is predominantly driven through histamine-driven vascular leakage and mucosal edema, compounded by abnormal muscle contraction and neural hypersensitivity. The swelling is largely edematous and inflammatory, not purely gaseous, explaining why mast-cell–mediated bloating often feels like tightness or pressure rather than gas that can be released.
Whereas Histamine induced H2 receptor activation enhances gastric acid secretion from parietal cells, which can contribute to symptoms of heartburn / reflux. Nausea is also highly possible as the result of excessive histamine causing vagal nerve stimulation or chemoreceptor activation.
Common foods that trigger mast cell degranulation include but are not limited to:
-
Sulfites - Wine
-
Benzoates and parabens - processed sauces, soft drinks
-
Nitrates/nitrites - cured meats
-
Artificial colors
-
Monosodium glutamate (MSG)
Neurological Symptoms
-
Migraines
-
Sleep Disturbances
-
Intense + Vivid Dreams
-
Motion Sickness
-
Anxiety Symptoms
-
Irritability
Histamine functions as a central nervous system neurotransmitter, particularly in regions regulating arousal, cognition, and circadian rhythm. It acts through H1 and H3 receptors, with H1 activation linked to wakefulness and sensory arousal. Overstimulation causes racing thoughts and sleep disturbances whereby sounds or movement can easily provoke arousal.
Histamine can also lead to more vivid and intense dreams because histamine also stimulates brain regions such as the amygdala and the sympathetic nervous system, amplifying the emotional tone of dream content, sometimes resulting in restless or distressing dream experiences. Clinical studies have shown that antihistamines, by dampening histamine activity, can decrease dream anxiety, and promote more restorative REM patterns, leading to calmer dream experiences.
Furthermore, Histamine H₃ receptors act as autoreceptors and heteroreceptors in the brain. This means they regulate not only the release of histamine itself but also other key neurotransmitters such as acetylcholine, dopamine, and norepinephrine. Under normal conditions, H₃ receptors maintain balance by providing inhibitory feedback, preventing excessive neurotransmitter release.
However, when histamine levels are chronically elevated, this feedback system becomes dysregulated. The overstimulation of H₃ receptors suppresses the release of acetylcholine, dopamine, and norepinephrine, leading to neurotransmitter imbalance. At the same time, excess histamine can activate microglia and mast cells in the central nervous system, promoting neuroinflammation. This combination of inflammation and neurochemical disruption can manifest as anxiety and irritability, migraines, brain fog and mood disturbances.
In relation to Motion Sickness, when there is a mismatch between what the body senses, like inner ear motion and what the eyes perceive, such as a stable environment, it activates histamine-producing neurons in the hypothalamus. These neurons send signals to the brain’s emetic (vomiting) center via histamine H1 receptors, triggering symptoms like nausea, vomiting and dizziness.
Therefore Elevated histamine levels can therefore increase the likelihood and severity of motion sickness. This explains why antihistamines, specifically H1 receptor blockers, are some of the most effective medications used to prevent and manage motion sickness symptoms.
Triggered Respiratory Symptoms
-
Sneezing
-
Persistent Clear Mucus
-
Cough
-
Shortness of breath
Mast cell activation can definitely be brought on by environmental triggers, because mast cells act as sentinels, at the body’s borders such as the skin, airways and sinuses, and respond rapidly to outside stimuli.
Common Triggers include:
-
Allergens: pollen, dust mites, mold spores, animal dander
-
Temperature changes: cold air, heat, humidity, sudden shifts
-
Irritants: smoke, pollution, perfumes, strong chemical smells
-
Stress: both emotional and physical stress
-
Exercise or physical pressure: exertion or friction
In relation to inhaled substances that stimulate mast cells in the nasal cavity and bronchial epithelium, they trigger H1 and H2 receptors. H1 receptor activation on increased vascular permeability, leading to mucosal edema (swelling), nasal congestion, and sneezing. It also stimulates sensory nerves, resulting in itching and running nose. H1 and H2 receptors on bronchial smooth muscle cells induce smooth muscle contractions promoting bronchoconstriction and shortness of breath.
Overall, this complex interplay of mast cell-derived mediators, histamine receptor activation, and eosinophilic inflammation forms the core of respiratory allergic responses, and underscores why interventions such as mast cell stabilizers are pivotal.
Triggered Skin Symptoms
-
Urticaria - Hives
-
Reactive or Sensitive Skin
-
Contact Dermatitis
-
Redness and itching
-
Facial and chest flushing
-
Swelling around the eyes
The skin contains a high density of mast cells within its connective tissue, making it especially responsive to triggers such as:
-
Stress and emotional responses
-
Heat or temperature changes
-
Chemicals in skin products
-
Environmental allergens
When activated, mast cells release histamine, which binds to H1 receptors in the skin. This causes blood vessels to dilate and become more permeable, producing the classic flare reactions of redness, swelling, raised welts, or itching. The upper chest and face have dense superficial capillary networks and thin skin, which makes this vasodilation and subsequent redness more visible.
Beyond histamine, mast cells also release pro-inflammatory cytokines such as IL-4 and IL-13, which promote a Th2-dominant immune response associated with heightened sensitivity to environmental and topical allergens. With repeated activation of mast cells they can increase in number, which then increases the risk of reactivity to such substances, creating reactive or sensitive skin.
Cardiovascular Symptoms
-
Hypotension / low blood pressure
-
Lightheadedness or Dizziness
-
Heart Palpitations
Histamine released from mast cells causes potent vasodilation via H1 and H2 receptors on endothelial and smooth muscle cells. This leads to a decrease in vascular resistance and subsequent tachycardia. H2 receptors in the myocardium also modulate contractility and rhythm, potentially contributing to palpitations.
Musculoskeletal Symptoms
-
Myalgia - Muscle Pain
-
Arthralgia - Joint pain
-
Fibromyalgia like symptoms
Mast cells infiltrate connective tissue and muscle fascia. Upon degradation, they release TNF-α and histamine, which sensitize sensory nerve endings. These inflammatory mediators can promote neurogenic inflammation, central sensitization, and pain amplification, hallmarks of fibromyalgia.
Genitourinary and Hormonal Symptoms
-
Painful Menstruation
-
Pelvic Discomfort
-
Urinary Urgency or Frequency
During the luteal phase of the menstrual cycle, estrogen levels rise, enhancing mast cell activation and histamine release. In individuals with an already heightened level of mast cell activity, this additional estrogen-driven degranulation can markedly amplify inflammatory signaling within reproductive tissues. The result is increased uterine contractility, pelvic congestion, and pain sensitivity, contributing to more pronounced pain during menstruation.
Similarly, excessive mast cell activation in the lower urinary and pelvic tissues can aggravate smooth muscle spasm, neurogenic inflammation, and local hypersensitivity, producing symptoms such as urinary urgency, pelvic discomfort, or burning sensations that worsen cyclically with hormonal fluctuations.
Eye Symptoms
-
Itchy eyes
-
Eye redness
-
Morning or persistent periorbital swelling – fluid retention around the eye
-
Epiphora – watering eyes
Mast cell degranulation in the conjunctiva triggers vasodilation, sensory nerve irritation, and glandular secretion, leading to redness, itching, and tearing. In addition, histamine release increases vascular permeability, allowing fluid to leak into the surrounding tissues. This encourages periorbital swelling, which is often most noticeable in the morning due to fluid accumulation overnight.
Temperature Dysregulation
-
Warm Skin
-
Profuse Sweating
-
Fluctuating Temperature Sensations
When histamine levels rise, it binds to H₁ and H₂ receptors on vascular smooth muscle and endothelial cells. Activation of these receptors causes nitric oxide (NO) release, leading to vasodilation and increased blood flow to superficial skin vessels. This redistribution of blood elevates skin temperature, producing warmth.
At the same time, histamine interacts with thermoregulatory centers in the hypothalamus, slightly raising metabolic activity and stimulating sweat gland output to help dissipate excess heat. However, when histamine release is excessive or systemic the response becomes exaggerated, resulting in profuse sweating, warmth, and fluctuating temperature sensations, particularly when exercising but even in the absence of infection or exertion.
Causes
Helminth (worm) Infection
Digestive helminth (worm) infections engage the same type 2 immune pathways that underlie mast cell activation. This is because helminths stimulate the secretion of inflammatory cytokines IL-4, IL-5, and IL-13. These cytokines promote IgE production and mast cell priming. Then when helminths attach to the IgE antibodies on the surface of a mast cell, the release of histamine occurs.
For this reason Mast Cell Activation will only be indicated for treatment in the case of further causes identified, otherwise it is only necessary to test and treat the worm infection.
Inorganic Chemical Exposure
Mast cells are concentrated at environmental interfaces such as the airways, skin and gut. They are designed to react to foreign antigens, but modern synthetic chemicals and biogenic toxins are novel exposures outside human evolutionary adaptation.
Therefore high-dose exposure to a host of inorganic substances at repeated low-level exposure can cause mast cells to become sensitized. Once sensitized, re-exposure to even small amounts of the same or unrelated chemicals can provoke exaggerated mediator release, which is described as Toxicant-Induced Loss of Tolerance (TILT). [42]
-
Pesticides
-
Solvents
-
Perfumes + Fragrance
-
Cleaning products
-
New construction materials.
-
Smoke
-
Exhaust fumes
-
Mold and Mycotoxins
-
Plasticizers: phthalates, bisphenols, dioxins
Stress [ SNS Hyperactivity ]
Acute and chronic psychological stress elevates corticotropin-releasing hormone (CRH), which directly stimulates mast cell degranulation in the skin and GI tract. The HPA axis dysregulation also affects intestinal barrier integrity and promotes Th2 immune bias, both of which increase susceptibility to histamine-mediated inflammation.
Dysbiosis
When the gut has an imbalance of beneficial and harmful microbes, it disrupts the immune system’s ability to regulate inflammation and tolerance. In this state, beneficial bacteria that normally promote regulatory T cells (Tregs) and produce short-chain fatty acids (SCFAs) like butyrate are reduced. Without these signals, Treg levels drop, leading to less production of calming cytokines like IL-10 and TGF-β, which normally help prevent overactivation of mast cells.
Dysbiosis also promotes an overactive Th2 immune response, which increases production of IgE antibodies and primes mast cells to release histamine and other inflammatory chemicals. This leads to heightened sensitivity and activation.
Furthermore, dysbiosis also weakens the gut barrier, allowing toxins and antigens to enter the bloodstream. This further activates immune responses and mast cells.
Intestinal Permeability
Mast cells are abundant in the gut and when activated by stress or bacterial signals, release inflammatory mediators which impair the tight junctions between epithelial cells and increase paracellular permeability. This is one part of the dysfunction that encourages intestinal permeability, and the allowance of larger molecules and bacteria to cross into circulation.
The exposure of such microbial toxins and food antigens into the bloodstream then increases antigenic load and leads to mast cells becoming exposed to a greater variety of antigens, which can trigger hyperresponsiveness.
Liver Insufficiency
When the liver becomes impaired or chronically inflamed, it triggers a cascade of immune changes that promote mast cell activation and accumulation within liver tissue. When mast cells within the liver become activated, their effects are not confined to the liver itself. These cells also release large amounts of histamine into the local tissue and circulation because the liver is highly vascularized and centrally connected to systemic blood flow. Therefore easily entering into the bloodstream and exerting effects throughout the body.
Furthermore, when liver function declines the liver releases inflammatory signals and growth factors SCF, IL-33, and TNF-α. These molecules bind to receptors on mast cells, stimulating their proliferation and activation. The more severe the liver insufficiency, the higher the mast cell infiltration and activation. [44]
Candidiasis
When Candida interacts with mast cells, it displays cell-wall sugars like β-glucans and mannans, which are detected by receptors on mast cells. Once engaged, candida activates intracellular signaling cascades which function as amplifiers, creating a stronger broadcast by switching on transcription factors that heighten the release of histamine. [40][41]
Latent Viral Reactivation
Latent viruses enter a dormant (inactive) state after the initial infection, residing in the body without presenting obvious symptoms. This latent state can last for months, years, or even a lifetime, but under certain conditions, these viruses can reactivate. Latent viruses include:
-
Herpes Simplex Virus Type 1 (HSV-1)
-
Herpes Simplex Virus Type 2 (HSV-2)
-
Varicella Zoster Virus (VZV)
-
Epstein-Barr Virus (EBV)
-
Cytomegalovirus (CMV)
In relation to Mast Cell Activation, mast cells are a natural response to viruses and in acute infection will promote interferons, cytokines, and immune cell recruitment in order to fight the infection. Whereas in chronic repeated reactivation of these latent viruses mast cell hyperplasia can occur. Mast cell hyperplasia causes an abnormal increase in the number of mast cells in tissue, which causes the immune environment to shift from protective to pathological, exaggerating mast cell activation and amplifying symptoms.
Studies have demonstrated Epstein-Barr Virus infection can play a significant role in amplifying allergic responses. The researchers examined 46 patients who were anti-Epstein Barr antigen-positive and found that those with EBV had heightened immune activity and a greater sensitivity to allergens than allergic patients without EBV. Specifically, these individuals exhibited increased responsiveness to specific allergens, reacted to a wider range of allergens, and had significantly elevated numbers of IgE-positive immune cells.
Hyperestrogenism
Estrogen enhances mast cell sensitivity and histamine release, while progesterone stabilizes mast cells. Hormonal fluctuations, especially during the luteal phase or perimenopause may increase mast cell degranulation and exacerbate symptoms.
References
[1] https://www.metagenicsinstitute.com.au/trade-presenters/allergy-reactivity
[2] https://www.bioceuticals.com.au/education/articles/histamine-intolerance
[3].https://bioconceptsengage.com.au/eresources/strain-specificity-probiotic-allies-in-allergy-and-autoimmunity
[4] https://www.metagenicsinstitute.com.au/tech-data/quercetin-bromelain-aller7-allergy
[5].https://www.biomedica.com.au/media/contentmanager/content/Beta_Glucans_Technical_Sheet.pdf
[6].https://www.biomedica.com.au/media/contentmanager/content/Histamine_Technical_Sheet.pdf
[7] https://pmc.ncbi.nlm.nih.gov/articles/PMC11054089/
[8] https://pmc.ncbi.nlm.nih.gov/articles/PMC3389341/
[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC10660865/
[10].https://www.sciencedirect.com/science/article/abs/pii/S1471489218300717
[11] https://www.ncbi.nlm.nih.gov/books/NBK27117/
[12].https://www.sciencedirect.com/science/article/abs/pii/S0091674986800811
[13] https://pubmed.ncbi.nlm.nih.gov/23528820/
[14].https://www.sciencedirect.com/science/article/pii/S095279152030056X
[15] https://www.jacionline.org/article/S0091-6749(18)30225-2/fulltext
[16] https://pubmed.ncbi.nlm.nih.gov/32783547/
[17] https://www.metagenicsinstitute.com.au/tech-data/vitamin-d3
[18] https://pubmed.ncbi.nlm.nih.gov/35776034/
[19].https://bernardsudan.net/dead-sea-salts-as-a-new-approach-for-the-treatment-of-seborrheic-dermatitis/
[20] https://pmc.ncbi.nlm.nih.gov/articles/PMC10094402/
[21] https://www.jstage.jst.go.jp/article/jnsv/59/6/59_560/_pdf
[22] https://pmc.ncbi.nlm.nih.gov/articles/PMC4412389/
[23] https://pmc.ncbi.nlm.nih.gov/articles/PMC9405764/
[24] https://pmc.ncbi.nlm.nih.gov/articles/PMC2914320/
[25] https://pmc.ncbi.nlm.nih.gov/articles/PMC2914320/
[26] https://pmc.ncbi.nlm.nih.gov/articles/PMC6384425/
[27] https://pmc.ncbi.nlm.nih.gov/articles/PMC9748122/
[28] https://pubmed.ncbi.nlm.nih.gov/12884291/
[29] https://pmc.ncbi.nlm.nih.gov/articles/PMC3488912/
[30] https://pmc.ncbi.nlm.nih.gov/articles/PMC9801018/
[31] https://pmc.ncbi.nlm.nih.gov/articles/PMC8501420/
[32] https://pmc.ncbi.nlm.nih.gov/articles/PMC9744621/
[33].https://www.researchgate.net/publication/311912908
[34] https://www.researchgate.net/publication/40728583
[35] https://pubmed.ncbi.nlm.nih.gov/14708456/
[36] https://pmc.ncbi.nlm.nih.gov/articles/PMC3708419/
[37] https://www.metagenicsinstitute.com.au/tech-data/lp33-lgg-immune-control
[38].https://www.metagenicsinstitute.com.au/tech-data/Lactobacillus-plantarum-lactobacillus-paracasei-lactobacillus-rhamnosus
[39] https://pmc.ncbi.nlm.nih.gov/articles/PMC8209461
[40].https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02829/full
[41].https://link.springer.com/article/10.1007/s10875-022-01267-9
[42] https://pmc.ncbi.nlm.nih.gov/articles/PMC10660865/
[43] https://www.jacionline.org/article/S0091-6749(22)01338-0/
[44] https://pmc.ncbi.nlm.nih.gov/articles/PMC9513450/
bottom of page